This study compound was initial documented by Hoffman-La Roche in 2009. It’s one among various benzodiazepines during the imidazobenzodiazepine subgroup considered to supply nootropic Rewards.This drug was invented by Schlesinger Walter and promoted from the early 80s. It was sold as currently being “much less harmful” than chlordiazepoxide (